KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Change in Taxes (2016 - 2025)

Historic Change in Taxes for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $610.0 million.

  • Amgen's Change in Taxes rose 14696.36% to $610.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.6 billion, marking a year-over-year increase of 4665.37%. This contributed to the annual value of -$1.0 billion for FY2024, which is 193.99% up from last year.
  • As of Q3 2025, Amgen's Change in Taxes stood at $610.0 million, which was up 14696.36% from -$2.4 billion recorded in Q2 2025.
  • Amgen's Change in Taxes' 5-year high stood at $610.0 million during Q3 2025, with a 5-year trough of -$2.4 billion in Q2 2025.
  • Its 5-year average for Change in Taxes is -$276.1 million, with a median of $53.0 million in 2024.
  • Per our database at Business Quant, Amgen's Change in Taxes soared by 51153.85% in 2022 and then crashed by 557857.14% in 2024.
  • Amgen's Change in Taxes (Quarter) stood at -$135.0 million in 2021, then fell by 14.81% to -$155.0 million in 2022, then crashed by 1209.03% to -$2.0 billion in 2023, then skyrocketed by 102.61% to $53.0 million in 2024, then surged by 1050.94% to $610.0 million in 2025.
  • Its last three reported values are $610.0 million in Q3 2025, -$2.4 billion for Q2 2025, and $104.0 million during Q1 2025.